t
Barclays PLC submitted a Form 8.3 disclosure on 02 March 2026, detailing its interests and dealings in Spire Healthcare Group PLC's 1p ordinary shares as of 27 February 2026. Following these dealings, Barclays PLC held total interests of 4,560,940 shares (1.13%) and total short positions of 3,023,335 shares (0.75%). On 27 February 2026, Barclays PLC undertook purchases of 888,211 shares and sales of 772,619 shares, in addition to various cash-settled derivative transactions.
| Date | 2 Mar 2026 |
| Time | 12:46:18 |
| Category | Holding(s) in company |
| ID | 9665U |
|
FORM 8.3 |
|||||||
|
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY |
|||||||
|
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR |
|||||||
|
MORE |
|||||||
|
Rule 8.3 of the Takeover Code (the "Code") |
|||||||
|
1. |
KEY INFORMATION |
||||||
|
(a) |
Full name of discloser: |
|
Barclays PLC. |
||||
|
(b) |
Owner or controller of interest and short |
|
|||||
|
|
positions disclosed, if different from 1(a): |
||||||
|
(c) |
Name of offeror/offeree in relation to whose |
SPIRE HEALTHCARE GROUP PLC |
|||||
|
|
relevant securities this form relates: |
||||||
|
(d) |
If an exempt fund manager connected with an |
|
|||||
|
|
offeror/offeree, state this and specify identity of |
||||||
|
|
offeror/offeree: |
||||||
|
(e) |
Date position held/dealing undertaken: |
27 Feb 2026 |
|||||
|
(f) |
In addition to the company in 1(c) above, is the discloser making |
NO |
|
|
|||
|
|
disclosures in respect of any other party to the offer? |
|
|
||||
|
2. |
POSITIONS OF THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Interests and short positions in the relevant securities of the offeror or offeree |
|
|||||
|
|
to which the disclosure relates following the dealing(if any) |
|
|||||
|
Class of relevant security: |
1p ordinary |
||||||
|
|
Interests |
Short Positions |
|||||
|
|
Number |
(%) |
Number |
(%) |
|||
|
(1) |
Relevant securities owned |
|
|
|
|
||
|
|
and/or controlled: |
|
|
2,418,367 |
0.60% |
2,366,967 |
0.59% |
|
(2) |
Cash-settled derivatives: |
|
|
|
|
||
|
|
|
|
|
2,142,573 |
0.53% |
656,368 |
0.16% |
|
(3) |
Stock-settled derivatives (including options) |
|
|
|
|
||
|
|
and agreements to purchase/sell: |
|
|
0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
|
|
|
|
|
|
TOTAL: |
|
|
4,560,940 |
1.13% |
3,023,335 |
0.75% |
|
(b) |
Rights to subscribe for new securities (including directors and other executive |
|
|||||
|
|
options) |
|
|
|
|
|
|
|
Class of relevant security in relation to |
|
|
|
|
|||
|
which subscription right exists |
|
|
|
|
|||
|
Details, including nature of the rights |
|
|
|
|
|||
|
concerned and relevant percentages: |
|
|
|
|
|||
|
3. |
DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Purchases and sales |
|
|
|
|
|
|
|
Class of relevant |
Purchase/sale |
Number of |
Price per unit |
||||
|
security |
|
securities |
|
||||
|
1p ordinary |
Purchase |
629,700 |
2.0300 GBP |
||||
|
1p ordinary |
Purchase |
115,158 |
2.0298 GBP |
||||
|
1p ordinary |
Purchase |
95,224 |
2.0350 GBP |
||||
|
1p ordinary |
Purchase |
17,597 |
2.0250 GBP |
||||
|
1p ordinary |
Purchase |
15,172 |
2.0283 GBP |
||||
|
1p ordinary |
Purchase |
4,535 |
2.0233 GBP |
||||
|
1p ordinary |
Purchase |
2,933 |
2.0150 GBP |
||||
|
1p ordinary |
Purchase |
1,980 |
2.0307 GBP |
||||
|
1p ordinary |
Purchase |
1,899 |
2.0400 GBP |
||||
|
1p ordinary |
Purchase |
1,137 |
2.0222 GBP |
||||
|
1p ordinary |
Purchase |
1,022 |
2.0252 GBP |
||||
|
1p ordinary |
Purchase |
816 |
2.0205 GBP |
||||
|
1p ordinary |
Purchase |
508 |
2.0297 GBP |
||||
|
1p ordinary |
Purchase |
342 |
2.0254 GBP |
||||
|
1p ordinary |
Purchase |
60 |
2.0253 GBP |
||||
|
1p ordinary |
Purchase |
28 |
2.0282 GBP |
||||
|
1p ordinary |
Sale |
665,220 |
2.0300 GBP |
||||
|
1p ordinary |
Sale |
56,652 |
2.0350 GBP |
||||
|
1p ordinary |
Sale |
21,004 |
2.0239 GBP |
||||
|
1p ordinary |
Sale |
15,656 |
2.0309 GBP |
||||
|
1p ordinary |
Sale |
14,000 |
2.0281 GBP |
||||
|
1p ordinary |
Sale |
87 |
2.0250 GBP |
||||
|
|
|
|
|
|
|
|
|
|
(b) |
Cash-settled derivative transactions |
|
|||||
|
Class of |
Product |
Nature of dealing |
Number of |
Price per |
|||
|
relevant |
description |
|
reference |
unit |
|||
|
security |
|
|
securities |
|
|||
|
1p ordinary |
SWAP |
Increasing Long |
172 |
2.0250 GBP |
|||
|
1p ordinary |
SWAP |
Increasing Long |
56,652 |
2.0350 GBP |
|||
|
1p ordinary |
SWAP |
Increasing Long |
1,466 |
2.0397 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
2,933 |
2.0150 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
60 |
2.0253 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
342 |
2.0254 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
3,181 |
2.0266 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
345 |
2.0271 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
355 |
2.0273 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
28 |
2.0283 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
64,820 |
2.0300 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
6,046 |
2.0301 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
1,980 |
2.0307 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Long |
95,224 |
2.0350 GBP |
|||
|
1p ordinary |
CFD |
Increasing Long |
21,004 |
2.0239 GBP |
|||
|
1p ordinary |
CFD |
Increasing Long |
33 |
2.0251 GBP |
|||
|
1p ordinary |
CFD |
Increasing Long |
531,471 |
2.0300 GBP |
|||
|
1p ordinary |
CFD |
Decreasing Long |
275 |
2.0201 GBP |
|||
|
1p ordinary |
CFD |
Decreasing Long |
4,535 |
2.0234 GBP |
|||
|
1p ordinary |
CFD |
Decreasing Long |
17,597 |
2.0250 GBP |
|||
|
1p ordinary |
CFD |
Decreasing Long |
530,343 |
2.0300 GBP |
|||
|
|
|
|
|
|
|
|
|
|
(c) |
Stock-settled derivative transactions (including options) |
|
|||||
|
(i) |
Writing, selling, purchasing or varying |
|
|||||
|
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
|
of |
description |
purchasing, |
of |
price |
|
date |
money |
|
relevant |
|
selling, |
securities |
per unit |
|
|
paid/ |
|
security |
|
varying etc |
to which |
|
|
|
received |
|
|
|
|
option |
|
|
|
per unit |
|
|
|
|
relates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercise |
|
|
|
|
|
|
|
Class of relevant |
Product description |
Exercising/ exercised against |
Number of |
Exercise price per |
|||
|
security |
|
|
securities |
unit |
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
(d) |
Other dealings (including subscribing for new securities) |
|
|||||
|
Class of relevant |
Nature of Dealings |
Details |
Price per unit (if |
||||
|
security |
|
|
applicable) |
||||
|
|
|
|
|
||||
|
4. |
OTHER INFORMATION |
||||||
|
(a) |
Indemnity and other dealings arrangements |
|
|||||
|
Details of any indemnity or option arrangement, or any agreement or understanding, |
|
|
|||||
|
formal or informal, relating to relevant securities which may be an inducement to deal |
|
|
|||||
|
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party |
|
||||||
|
to the offer or any person acting in concert with a party to the offer: |
|
|
|
||||
|
NONE |
|||||||
|
(b) |
Agreements, arrangements or understandings relating to options or derivatives |
|
|||||
|
Details of any agreement, arrangement or understanding, formal or informal, between |
|
|
|||||
|
the person making the disclosure and any other person relating to: |
|
|
|||||
|
(i) the voting rights of any relevant securities under any option; or |
|
|
|
||||
|
(ii) the voting rights of future acquisition or disposal of any relevant securities to which |
|
|
|||||
|
any derivative is referenced: |
|
|
|
|
|
|
|
|
NONE |
|||||||
|
(c) |
Attachments |
|
|
|
|
|
|
|
Is a Supplemental Form 8 (Open Positions) attached? |
NO |
||||||
|
Date of disclosure: |
02 Mar 2026 |
||||||
|
Contact name: |
Large Holdings Regulatory Operations |
||||||
|
Telephone number: |
020 3134 7213 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|